Open Emergency Modal

Overview of Specialty

At Yashoda Medicity and Yashoda Super Speciality Hospital, Kaushambi , the Pediatric Oncology & Hematology Department is dedicated to the comprehensive care of children with blood disorders and childhood cancers. We provide compassionate, multidisciplinary treatment that combines medical expertise, advanced technologies, and holistic support for the child and family. Our services encompass the full spectrum of pediatric blood and cancer conditions, from diagnosis and therapy to long-term follow-up and survivorship care. With access to advanced pediatric ICUs, hematology labs, and supportive care systems, we ensure that every child receives safe, evidence-based, and personalized treatment.

Conditions Treated

  • Leukemia (Acute and Chronic): The most common childhood cancer, beginning in the bone marrow and affecting white blood cells. Symptoms often include fever, fatigue, infections, or unexplained bruising.
  • Lymphoma: Cancers of the lymphatic system, including Hodgkin and Non-Hodgkin lymphoma, presenting with swollen lymph nodes, night sweats, or persistent fevers.
  • Solid Tumors: Wilms tumor, neuroblastoma, hepatoblastoma, brain tumors, and sarcomas, managed with multidisciplinary treatment approaches.
  • Bleeding & Clotting Disorders: Hemophilia, Von Willebrand disease, and thrombophilia, requiring specialized clotting factor replacement or monitoring.
  • Bone Marrow Failure Syndromes: Aplastic anemia, Fanconi anemia, and other inherited marrow failure disorders.
  • Anemias: Including thalassemia, sickle cell disease, and nutritional anemias requiring lifelong monitoring or transfusion support.
  • Myeloproliferative and Myelodysplastic Disorders: Rare but serious conditions requiring targeted or transplant-based therapy.

Diagnostic Facilities

  • Complete Blood Count (CBC) and Peripheral Smear Evaluation
  • Advanced Immunophenotyping & Flow Cytometry
  • Bone Marrow Aspiration and Biopsy
  • Cytogenetics and Molecular Diagnostics (PCR, FISH, Next-Gen Sequencing)
  • Imaging Support: CT, MRI, PET-CT for staging and follow-up

Treatment Options

  • Chemotherapy: Child-specific regimens to treat leukemia, lymphoma, and solid tumors.
  • Targeted Therapy: Drugs tailored to specific genetic mutations for greater effectiveness and fewer side effects.
  • Immunotherapy: Monoclonal antibodies and CAR-T therapy, designed to harness the body’s immune system against cancer cells.
  • Bone Marrow & Stem Cell Transplant: For leukemia, lymphoma, marrow failure, and genetic blood disorders, with facilities for both allogeneic and autologous transplants.
  • Radiation Therapy: When indicated, delivered in coordination with pediatric radiation oncologists.
  • Supportive Care: Growth factors, antibiotics, transfusion support, nutritional rehabilitation, and psycho-social counseling.
  • Palliative and Survivorship Programs: Focused on improving quality of life, long-term monitoring, and reintegration into normal life.

Services Available

  • Dedicated Pediatric Oncology Ward with child-friendly design
  • Pediatric ICU and NICU support for critical cases
  • Pediatric Day Care Chemotherapy Unit
  • Long-term follow-up clinics for cancer survivors
  • Integrated Nutritional & Psychological Support

Technologies

  • Pediatric Blood Bank Services with leukoreduced, irradiated components
  • Advanced Imaging (PET-CT, MRI, Ultrasound) for pediatric tumor staging
  • State-of-the-art Pediatric Bone Marrow Transplant Unit

Patient Testimonials

Frequently Asked Questions

A bone marrow transplant is a medical procedure that replaces diseased or damaged bone marrow with healthy stem cells to restore normal blood and immune function.

Recovery varies depending on transplant type and patient condition but generally takes 3–6 months, with lifelong monitoring.

No. If a matched family donor is unavailable, unrelated donors, haploidentical family members, or cord blood units can be used.

Risks include infections, graft-versus-host disease (GVHD), bleeding, and relapse. With improved supportive care, success rates have significantly increased.

Yes. BMT is often a life-saving option for pediatric patients with thalassemia, sickle cell disease, immunodeficiencies, or leukemias.
t>